Multiple Myeloma: Newest Treatments for Relapsed/Refractory MM | For Patients & Caregivers

This video is episode 2 in our educational series, "Newest Treatment for Multiple Myeloma," made especially for multiple myeloma patients and their caregivers to navigate this fast-changing landscape of options.

In this episode, top multiple myeloma specialist, Dr. Rafael Fonseca of Mayo Clinic, describes his typical treatment regimen for multiple myeloma patients who’ve become triple-class refractory, or whose disease isn’t responding to the three standard classes of drugs prescribed to myeloma patients: proteasome inhibitors, immunomodulatory agents (IMiDs), and monoclonal antibodies.

He delves into selinexor, melflufen, and belantamab mafodotin, as well as commonly reported side effects and how to manage them.

Full transcript: https://www.thepatientstory.com/refra...